Literature DB >> 1547070

Peroneal artery bypass: a multifactorial analysis.

C K Shortell1, K Ouriel, J A DeWeese, R M Green.   

Abstract

Sixty-two bypass grafts to the peroneal artery were performed at the University of Rochester Medical Center between 1984 and 1990. An autogenous conduit was used in 45 patients and a prosthetic conduit in 17 patients. Primary cumulative patency rates were 49% at two years and 30% at four years following operation. Limb salvage was achieved in 68% of patients. The two year cumulative patency rate was significantly better when the peroneal artery was of good quality arteriographically compared with those in which stenoses were present (75% versus 25%, p less than 0.05); in patients without inflow disease compared with patients with inflow disease (56% versus 11%, p less than 0.05); and in saphenous vein grafts compared with prosthetic grafts (55% versus 17%, p less than 0.05). The factors that did not influence patency were the presence of a direct peroneal collateral vessel filling a pedal vessel, age, sex, diabetes, and the size of the peroneal artery. The results of peroneal artery bypass in end-stage patients are dependent on the presence of adequate autogenous vein and a recipient peroneal vessel free of disease. Under these circumstances, the results of the procedure approach that of standard femorotibial reconstruction.

Entities:  

Mesh:

Year:  1992        PMID: 1547070     DOI: 10.1007/BF02000661

Source DB:  PubMed          Journal:  Ann Vasc Surg        ISSN: 0890-5096            Impact factor:   1.466


  2 in total

1.  Sural flap vascularization in arteritic patients: an anatomic study of 24 amputation specimens.

Authors:  S Malokov; D Casanova; G Magalon; A Branchereau
Journal:  Surg Radiol Anat       Date:  2003-07-18       Impact factor: 1.246

2.  Long-term results of in situ saphenous vein bypass. Analysis of 2058 cases.

Authors:  D M Shah; R C Darling; B B Chang; K M Fitzgerald; P S Paty; R P Leather
Journal:  Ann Surg       Date:  1995-10       Impact factor: 12.969

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.